Literature DB >> 752036

Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus.

A Ohneda, K Watanabe, K Horigome, T Sakai, Y Kai, S Oikawa.   

Abstract

In order to determine pancreatic alpha cell function in diabetes mellitus, plasma glucagon responses to either an oral glucose load or insulin-induced hypoglycemia were investigated. Plasma glucagon in 6 normal control subjects fell significantly after the administration of glucose, whereas the levels of plasma glucagon did not decrease after glucose ingestion in patients with diabetes mellitus. In the group with severe diabetes, whose fasting blood glucose exceeded 200 mg/100 ml, the plasma glucagon level rose after glucose administration instead of decreasing. In 6 patients with diabetes mellitus, plasma glucagon did not decrease but rather increased during a glucose tolerance test which was performed after treatment with insulin and/or diet. In 6 control subjects, there was a remarkable rise of plasma glucagon in response to insulin-induced hypoglycemia. In contrast, no significant rise in plasma glucagon was demonstrated in 19 diabetic subjects undergoing intravenous insulin test. Seven patients, in whom an insulin test was repeated after treatment with insulin, sulfonylurea, or diet had a small rise in peak plasma glucagon and an increase in the integrated area under the glucagon response curve. It is concluded that the abnormal glucagon response to changes in blood glucose might be a primary defect in diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 752036     DOI: 10.1210/jcem-46-3-504

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Alpha cell function in health and disease: influence of glucagon-like peptide-1.

Authors:  B E Dunning; J E Foley; B Ahrén
Journal:  Diabetologia       Date:  2005-08-13       Impact factor: 10.122

2.  Chronic fractalkine administration improves glucose tolerance and pancreatic endocrine function.

Authors:  Matthew Riopel; Jong Bae Seo; Gautam K Bandyopadhyay; Pingping Li; Joshua Wollam; Heekyung Chung; Seung-Ryoung Jung; Anne Murphy; Maria Wilson; Ron de Jong; Sanjay Patel; Deepika Balakrishna; James Bilakovics; Andrea Fanjul; Artur Plonowski; Duk-Su Koh; Christopher J Larson; Jerrold M Olefsky; Yun Sok Lee
Journal:  J Clin Invest       Date:  2018-03-05       Impact factor: 14.808

Review 3.  Clinical pharmacokinetics and pharmacodynamics of vildagliptin.

Authors:  Yan-Ling He
Journal:  Clin Pharmacokinet       Date:  2012-03-01       Impact factor: 6.447

4.  Glucose inhibits glucagon secretion by a direct effect on mouse pancreatic alpha cells.

Authors:  E Vieira; A Salehi; E Gylfe
Journal:  Diabetologia       Date:  2006-11-29       Impact factor: 10.122

5.  Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet.

Authors:  M Sörhede Winzell; C L Brand; N Wierup; U G Sidelmann; F Sundler; E Nishimura; B Ahrén
Journal:  Diabetologia       Date:  2007-05-04       Impact factor: 10.122

6.  Pharmacokinetics and pharmacodynamics of vildagliptin in patients with type 2 diabetes mellitus.

Authors:  Yan-Ling He; Denise Serra; Yibin Wang; Joelle Campestrini; Gilles-Jacques Riviere; Carolyn F Deacon; Jens J Holst; Sherwyn Schwartz; Jace C Nielsen; Monica Ligueros-Saylan
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

7.  Maternal insulin resistance and transient hyperglycemia impact the metabolic and endocrine phenotypes of offspring.

Authors:  Sevim Kahraman; Ercument Dirice; Dario F De Jesus; Jiang Hu; Rohit N Kulkarni
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-09-23       Impact factor: 4.310

8.  Lack of glucagon response in glucose counter-regulation in type 1 (insulin-dependent) diabetics: absence of recovery after prolonged optimal insulin therapy.

Authors:  G Bolli; G Calabrese; P De Feo; P Compagnucci; G Zega; G Angeletti; M G Cartechini; F Santeusanio; P Brunetti
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

9.  X-box binding protein 1 is essential for insulin regulation of pancreatic α-cell function.

Authors:  Masaru Akiyama; Chong Wee Liew; Shusheng Lu; Jiang Hu; Rachael Martinez; Ben Hambro; Robert T Kennedy; Rohit N Kulkarni
Journal:  Diabetes       Date:  2013-03-14       Impact factor: 9.461

10.  Pancreatic alpha cells in diabetic rats express active GLP-1 receptor: Endosomal co-localization of GLP-1/GLP-1R complex functioning through intra-islet paracrine mechanism.

Authors:  Koji Nakashima; Hideaki Kaneto; Masashi Shimoda; Tomohiko Kimura; Kohei Kaku
Journal:  Sci Rep       Date:  2018-02-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.